Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.9
-103.27%
Never
—
61x
80%
—
5 Years
Score2.9
Net Growth-103.27%
Net TrendNever
Net Income Consistency—
Rev Growth61x
Rev Trend80%
Revenue Consistency—
Autolus Therapeutics Ltd fundamental performance
Between 2020 and 2025, revenue grew from $ 1M to $ 75M and net income went from -$ 142M to -$ 288M. Revenue increased in 4 of those 5 years; net income in 0.
Autolus Therapeutics Ltd currently holds a 5-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.12 | — |
1 Year2025-08-12 | $ 2.15 | -1.62% |
5 Years2021-08-12 | $ 6.11 | -65.30% |
All Time2018-06-22 | $ 25.00 | -91.52% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-06-22 |
|---|---|---|---|---|
| Price | $ 2.12 | $ 2.15 | $ 6.11 | $ 25.00 |
| Return | — | -1.62% | -65.30% | -91.52% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 92M | -$ 288M | $ 229M |
| 2025 | $ 75M | -$ 288M | $ 300M |
| 2024 | $ 10M | -$ 220M | $ 588M |
| 2023 | $ 1M | -$ 208M | $ 239M |
| 2022 | $ 6M | -$ 148M | $ 382M |
| 2021 | $ 1M | -$ 142M | $ 310M |
| 2020 | $ 1M | -$ 142M | $ 154M |
| 2019 | $ 2M | -$ 123M | $ 211M |
| IPO2018 | $ 1M | -$ 31M | $ 189M |
| IPO2018 | $ 1M | -$ 31M | $ 189M |
Explore beyond AUTL
You're looking at Autolus Therapeutics Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
